Mars logo
You are currently viewing Mars Global in English
Choose a Market & Language
Mars Global
Africa
South Africa
Americas
Asia & Pacific
Australia
China
Indonesia
Korea
Taiwan, China
Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Greece
Hungary
Ireland
Lithuania
Netherlands
Norway
Poland
Portugal
Slovakia
Sweden
Switzerland
United Kingdom

Your Current Selection Global

Mars Search

Mars completes acquisition of Cerba HealthCare Group’s stake in French...

Mars completes acquisition of Cerba HealthCare Group’s stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE    

Investment in Cerba Vet and ANTAGENE to broaden and enhance access to diagnostics solutions in France and better serve more veterinary professionals and pets  

McLean, VA (July 2, 2024) — Mars, Incorporated (“Mars”) today announced that it has completed its previously announced acquisition of Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE now complement the diagnostics portfolio in Mars Petcare’s Science & Diagnostics division.  

Nefertiti Greene, President, Mars Science & Diagnostics, said: “We are excited to join forces with the teams from Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE complement Mars Science & Diagnostics, which includes a global veterinary diagnostics business, Antech(Opens a new window), and leading cat and dog genetic testing business Wisdom Panel(Opens a new window). Together we will further the Mars Petcare Purpose: A BETTER WORLD FOR PETS.”  

MEDIA CONTACT
Mars, Incorporated media inquiries:    
Kekst CNC  
James Lindsay  
[email protected]

About Mars, Incorporated
Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As a $50bn family-owned business, our diverse and expanding portfolio of leading pet care products and veterinary services support pets all around the world and our quality snacking and food products delight millions of people every day. We produce some of the world’s best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®, CESAR®, DOVE®, EXTRA®, M&M’s®, SNICKERS® and BEN’S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics.  The Mars Five Principles – Quality, Responsibility, Mutuality, Efficiency and Freedom – inspire our 150,000 Associates to act every day to help create a better world for people, pets and the planet.    

For more information about Mars, please visit www.mars.com. Join us on Facebook(Opens a new window)Twitter(Opens a new window)Instagram(Opens a new window)LinkedIn(Opens a new window) and YouTube(Opens a new window).

About Mars Science & Diagnostics  
Mars Science & Diagnostics is a division of Mars Petcare, a diverse business dedicated to one purpose: A BETTER WORLD FOR PETS. Science & Diagnostics brings together the power of leading pet health science with expertise across diagnostics, data, and technology to improve outcomes in pet health. Our veterinary diagnostics business Antech(Opens a new window) spans in-house diagnostic laboratory instruments and consumables, including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software and related software and support; reference laboratories around the globe; veterinary imaging and technology; education; and board-certified specialist support services. Our at-home diagnostics offering includes Wisdom Panel(Opens a new window), the world’s most accurate pet DNA test. For 60 years, our Waltham Petcare Science Institute(Opens a new window) has been advancing science to better understand pet health.      

About Cerba HealthCare  
Cerba HealthCare, a leading global player in medical diagnostics, aims to support the evolution of health systems towards more prevention. It draws on more than 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier, and optimize the effectiveness of personalized medicine.  

Every day, on five continents, the Group's 15,000 employees sustain the transformation of medicine, driven by one deep conviction: to advance diagnosis is to advance health. 

Cerba HealthCare, enlightening health

Additional information is available at www.cerbahealthcare.com(Opens a new window)